Darren Whitehouse

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Arginase Inhibition. Top assignees: Calithera Biosciences, Inc., The Institute for Pharmaceutical Discovery, LLC, Mars, Incorporated. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darren Whitehouse. Retrieved from https://idiyas.com/inventor/darren-whitehouse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 55.6

CIPO Patents = 2 (Patent Applications = 14)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 5.4

ph-index = 6

Forward Citations = 124(Granted Patents)

Location History:

Branford, CT (US) (2015)
McLean, VA (US) (2016 - 2018)
Westbrook, CT (US) (2007 - 2024)

Company Filing History:

5 out of 30

Calithera Biosciences, Inc.

patents

5 out of 16

The Institute for Pharmaceutical Discovery, LLC

Bristol-Myers Squibb Compnay

patents

5. 1 out of 1

Precision Pharmaceuticals, Inc.

patent

6. 1 out of 3

The Institutes for Pharmaceutical Discovery LLC

patents

7. 1 out of 834,570

Other

patents

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Arginase Inhibitors

Therapeutic Applications

Carboxylic Acids

Phenyl Substituted

Substituted Amino

Heterocycle Compounds

Iminothiazolidinones

HCV Replication

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12054501 - Compositions and methods for inhibiting arginase activity (2024-08-06),

2. 11021495 - Compositions and methods for inhibiting arginase activity (2021-06-01),

3. 10851118 - Compositions and methods for inhibiting arginase activity (2020-12-01),

4. 10844080 - Compositions and methods for inhibiting arginase activity (2020-11-24),

5. 10597411 - Compositions and methods for inhibiting arginase activity (2020-03-24),

6. 10538537 - Inhibitors of arginase and their therapeutic applications (2020-01-21),

7. 10287303 - Compositions and methods for inhibiting arginase activity (2019-05-14),

8. 10065974 - Compositions and methods for inhibiting arginase activity (2018-09-04),

9. 9994594 - Inhibitors of arginase and their therapeutic applications (2018-06-12),

10. 9266908 - Inhibitors of arginase and their therapeutic applications (2016-02-23),

11. 9040703 - Inhibitors of arginase and their therapeutic applications (2015-05-26),

12. 7524878 - Phenyl substituted carboxylic acids (2009-04-28),

13. 7498356 - Substituted amino carboxylic acids (2009-03-03),

14. 7465825 - Phenyl substituted carboxylic acids (2008-12-16),

15. 7358364 - Substituted carboxylic acids (2008-04-15),

Title: Innovator Spotlight: Darren Whitehouse

Introduction

Darren Whitehouse, an accomplished inventor based in Westbrook, Connecticut, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 18 patents, his work primarily focuses on innovative compositions that have the potential to impact cancer treatment.

Latest Patents

Among his latest patents, Darren has developed compositions and methods for inhibiting arginase activity. This disclosure introduces a novel class of compounds that exhibit activity inhibitory toward arginase, alongside pharmaceutical compositions comprised of these compounds. Furthermore, the methods of treating cancer utilizing these arginase inhibitors demonstrate promising applications in oncology.

Career Highlights

Darren has held pivotal roles in prominent companies such as Calithera Biosciences and Mars, Incorporated. His work in these organizations underscores his dedication to advancing pharmaceutical research and developing therapeutic solutions.

Collaborations

Throughout his career, Darren has collaborated with esteemed colleagues, including Michael C. Van Zandt and Eric Brian Sjogren. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the innovative outcomes of their joint efforts.

Conclusion

Darren Whitehouse continues to be a notable figure in the realm of invention and innovation. His commitment to developing treatments that inhibit arginase activity exemplifies the impactful work being done by inventors in the pharmaceutical sector. As research progresses, his contributions will undoubtedly play a crucial role in shaping future cancer therapies.

Profile summary based on public USPTO records.